ArticleViruses2026
Alignment-Free Machine Learning Serotype Classification of the Dengue Virus.
Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Dengue virus (DENV) serotyping is essential for epidemiological surveillance, clinical risk assessment, and vaccine evaluation, as the four dengue serotypes differ in pathogenicity, immune interactions, and population dynamics. Existing subtyping methods largely rely on sequence alignment and phylogenetic inference, which can be computationally intensive and unreliable for short, fragmented, or error-prone sequences commonly generated in diagnostic and surveillance settings. There is a need for fast, alignment-free serotyping approaches that maintain high accuracy across heterogeneous sequence lengths while remaining scalable, transparent, and suitable for real-world diagnostic inputs. We demonstrate that compact 3-mer composition features are sufficient for highly accurate dengue virus serotyping when coupled with a lineage-aware Random Forest classification framework. Using 64 normalized 3-mer frequency features per sequence with ambiguity masking and enforcing strict cluster-aware validation at both 99% and 95% nucleotide identity thresholds, our approach achieved near-perfect accuracy and macro-F1 scores on held-out internal test sets. To further ensure independence, external validation datasets were filtered to remove exact sequence matches and any sequences sharing ≥99% or ≥95% nucleotide identity with internal data. On these strictly independent external datasets, the model maintained 100% accuracy and macro-F1 performance, confirming robust generalization beyond database redundancy. Robustness analyses showed stable performance under contiguous sequence truncation down to 300 bp and in the presence of ambiguous nucleotides, indicating resilience to realistic diagnostic inputs. These results demonstrate that a lightweight, alignment-free, machine learning approach can rival alignment-dependent methods while maintaining strict lineage-aware evaluation controls. The proposed framework combines high predictive accuracy, probabilistic reliability, computational efficiency, and reproducible validation design, making it well suited for large-scale genomic surveillance, rapid pre-screening, and diagnostic decision-support applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.